The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer

Table 1

The characteristics of groups under investigation.

Group	N; (females)	Median age; (range)
Donors	64	53 (24 - 75)
Breast cancer patients	196	62 (23 – 91)
stage 0	14	65 (29 – 82)
stage 1	50	59 (32 – 79)
stage 2a	28	59 (23 – 80)
stage 2b	29	60 (35 – 79)
stage 3a	29	58 (31 – 78)
stage 3b	9	74 (69 – 79)
stage 3c	30	67 (50 – 91)
stage 4	7	54 (38 – 71)